Invesco
CLSD

Invesco’s Clearside Biomedical CLSD Stock Holding History

Invesco’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,477
Closed -$1.66M – 4046
2021
Q3 		$1.66M Buy
+18,477
New +$1.63M ﹤0.01% 2903
2019
Q1 		– Sell
-713
Closed -$11K – 3722
2018
Q4 		$11K Buy
+713
New +$33.5K ﹤0.01% 3775
2018
Q3 		– Sell
-8,666
Closed -$1.39M – 3890
2018
Q2 		$1.39M Buy
+8,666
New +$1.46M ﹤0.01% 2967

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco's CLSD Position: Q4 2021 in Review

Invesco sold out of Clearside Biomedical (CLSD) in Q4 2021, closing a stake of 18,477 shares — an estimated $1.66M sold.

Invesco first reported a position in CLSD in Q2 2018 and held it in 3 quarters. The position peaked at $1.66M in Q3 2021. 67 funds tracked by Wall St. Rank hold CLSD as of Q4 2021.

  • Invesco reported no remaining Clearside Biomedical position as of Q4 2021 after selling out during the quarter.
  • Invesco sold 18,477 Clearside Biomedical shares in Q4 2021, an estimated $1.66M.
  • Invesco first reported a position in Clearside Biomedical in Q2 2018 and held it in 3 quarters.
  • Invesco's Clearside Biomedical position peaked at $1.66M in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2021.

Based on Invesco's 13F filing for Q4 2021, filed 14 Feb 2022.